| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 152, 889-895, Copyright © 1998 by American Society for Investigative Pathology
REGULAR ARTICLES |
V Askanas, WK Engel, CC Yang, RB Alvarez, VM Lee and T Wisniewski
USC Neuromuscular Center, Los Angeles, California 90017-1912, USA.
Sporadic inclusion-body myositis (s-IBM) is the most common progressive muscle disease of older persons. The muscle biopsy demonstrates mononuclear cell inflammation and vacuolated muscle fibers containing paired helical filaments and 6- to 10-nm fibrils, both resembling those of Alzheimer disease brain and Congo red positivity. The term hereditary inclusion-body myopathies (h-IBMs) designates autosomal- recessive or autosomal-dominant disorders with muscle biopsies cytopathologically similar to s-IBM but without inflammation. Vacuolated muscle fibers of both s-IBM and the h-IBMs contain accumulations of several "Alzheimer-characteristic proteins" including beta-amyloid protein and beta-amyloid precursor protein, and their paired helical filaments are composed of phosphorylated tau. We used six well characterized antibodies against several residues of presenilin 1 (PS1) to immunostain muscle biopsies of 12 patients with s- IBM, 5 patients with autosomal-recessive inclusion-body myopathy, and 16 normal and disease controls. Seventy to eighty percent of the vacuolated muscle fibers of both s-IBM and autosomal-recessive inclusion-body myopathy had inclusions that were strongly PS1- immunoreactive, which by immunoelectron microscopy localized mainly to paired helical filaments and 6- to 10-nm filaments. None of the control biopsies had PS1-positive inclusions characteristic of the s- and h-IBM abnormal muscle fibers. Mutations of the newly discovered PS1 gene are responsible for early-onset familial Alzheimer disease (AD), and PS1 is abnormally accumulated in sporadic and familial AD brain. Our study provides the first demonstration of PS1 abnormality in non-neural tissue and in diseases other than AD and suggests that the cytopathogenesis in AD brain and IBM muscle may share similarities.
This article has been cited by other articles:
![]() |
R. A. Nixon Autophagy, amyloidogenesis and Alzheimer disease J. Cell Sci., December 1, 2007; 120(23): 4081 - 4091. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kitazawa, K. N. Green, A. Caccamo, and F. M. LaFerla Genetically Augmenting A{beta}42 Levels in Skeletal Muscle Exacerbates Inclusion Body Myositis-Like Pathology and Motor Deficits in Transgenic Mice Am. J. Pathol., June 1, 2006; 168(6): 1986 - 1997. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H. Yu, A. M. Cuervo, A. Kumar, C. M. Peterhoff, S. D. Schmidt, J.-H. Lee, P. S. Mohan, M. Mercken, M. R. Farmery, L. O. Tjernberg, et al. Macroautophagy--a novel {beta}-amyloid peptide-generating pathway activated in Alzheimer's disease J. Cell Biol., October 10, 2005; 171(1): 87 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rodova, K. F. Kelly, M. VanSaun, J. M. Daniel, and M. J. Werle Regulation of the Rapsyn Promoter by Kaiso and {delta}-Catenin Mol. Cell. Biol., August 15, 2004; 24(16): 7188 - 7196. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Sugarman, T. R. Yamasaki, S. Oddo, J. C. Echegoyen, M. P. Murphy, T. E. Golde, M. Jannatipour, M. A. Leissring, and F. M. LaFerla Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle PNAS, April 30, 2002; 99(9): 6334 - 6339. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Goebel and I. A.P Warlo Topical Review: Progress in Desmin-Related Myopathies J Child Neurol, September 1, 2000; 15(9): 565 - 572. [Abstract] [PDF] |
||||
![]() |
G. M. Wilczynski, W. K. Engel, and V. Askanas Association of Active Extracellular Signal-Regulated Protein Kinase with Paired Helical Filaments of Inclusion-Body Myositis Muscle Suggests Its Role in Inclusion-Body Myositis Tau Phosphorylation Am. J. Pathol., June 1, 2000; 156(6): 1835 - 1840. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. O. WELLER, A. MASSEY, Y.-M. KUO, and A. E. ROHER Cerebral Amyloid Angiopathy: Accumulation of A{beta} in Interstitial Fluid Drainage Pathways in Alzheimer's Disease Ann. N.Y. Acad. Sci., April 1, 2000; 903(1): 110 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Broccolini, W. K. Engel, R. B. Alvarez, and V. Askanas Paired Helical Filaments of Inclusion-Body Myositis Muscle Contain RNA and Survival Motor Neuron Protein Am. J. Pathol., April 1, 2000; 156(4): 1151 - 1155. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-W. Jin, M. G. Hearn, C. E. Ogburn, N. Dang, D. Nochlin, W. C. Ladiges, and G. M. Martin Transgenic Mice Over-Expressing the C-99 Fragment of ßPP with an {alpha}-Secretase Site Mutation Develop a Myopathy Similar to Human Inclusion Body Myositis Am. J. Pathol., December 1, 1998; 153(6): 1679 - 1686. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Fukuchi, D. Pham, M. Hart, L. Li, and J. R. Lindsey Amyloid-ß Deposition in Skeletal Muscle of Transgenic Mice : Possible Model of Inclusion Body Myopathy Am. J. Pathol., December 1, 1998; 153(6): 1687 - 1693. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Sugarman, T. R. Yamasaki, S. Oddo, J. C. Echegoyen, M. P. Murphy, T. E. Golde, M. Jannatipour, M. A. Leissring, and F. M. LaFerla Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle PNAS, April 30, 2002; 99(9): 6334 - 6339. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |